More research is needed so as to confirm that AGO2 plays a key role in the pathogenesis of depression and to provide additional evidence that the regulation of AGO2 expression or activation can be used as a tool in prevention of depression. This evidence concerns the gene AGO2 and depressive symptom measurement.